Annual Gross Margin
86.54%
-1.87%-2.12%
December 31, 2023
Summary
- As of February 7, 2025, YMAB annual gross profit margin is 86.54%, with the most recent change of -1.87% (-2.12%) on December 31, 2023.
- During the last 3 years, YMAB annual gross margin has fallen by -2.84% (-3.18%).
- YMAB annual gross margin is now -6.75% below its all-time high of 92.80%, reached on December 31, 2021.
Performance
YMAB Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Margin
87.82%
+1.04%+1.20%
September 30, 2024
Summary
- As of February 7, 2025, YMAB quarterly gross profit margin is 87.82%, with the most recent change of +1.04% (+1.20%) on September 30, 2024.
- Over the past year, YMAB quarterly gross margin has dropped by -3.45% (-3.78%).
- YMAB quarterly gross margin is now -10.63% below its all-time high of 98.27%, reached on March 31, 2021.
Performance
YMAB Quarterly Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Margin Formula
Gross Margin = Gross Profit
Revenue ✕ 100%
Revenue ✕ 100%
YMAB Gross Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.1% | -3.8% |
| 3 y3 years | -3.2% | -6.2% |
| 5 y5 years | - | -6.2% |
YMAB Gross Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -6.8% | at low | -6.2% | +13.2% |
| 5 y | 5-year | -6.8% | at low | -10.6% | +13.2% |
| alltime | all time | -6.8% | at low | -10.6% | +13.2% |
Y-mAbs Therapeutics Gross Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 87.82%(+1.2%) |
| Jun 2024 | - | 86.78%(-2.7%) |
| Mar 2024 | - | 89.23%(-2.2%) |
| Dec 2023 | 86.54%(-2.1%) | 91.27%(+4.8%) |
| Sep 2023 | - | 87.07%(+12.2%) |
| Jun 2023 | - | 77.60%(-13.5%) |
| Mar 2023 | - | 89.71%(-4.1%) |
| Dec 2022 | 88.41% | 93.58%(+16.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | 80.26%(-9.3%) |
| Jun 2022 | - | 88.52%(+7.2%) |
| Mar 2022 | - | 82.54%(-2.6%) |
| Dec 2021 | 92.80%(+3.8%) | 84.78%(-9.7%) |
| Sep 2021 | - | 93.87%(-2.5%) |
| Jun 2021 | - | 96.26%(-2.0%) |
| Mar 2021 | - | 98.27%(+9.9%) |
| Dec 2020 | 89.38% | 89.38% |
FAQ
- What is Y-mAbs Therapeutics annual gross profit margin?
- What is the all time high annual gross margin for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics annual gross margin year-on-year change?
- What is Y-mAbs Therapeutics quarterly gross profit margin?
- What is the all time high quarterly gross margin for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics quarterly gross margin year-on-year change?
What is Y-mAbs Therapeutics annual gross profit margin?
The current annual gross margin of YMAB is 86.54%
What is the all time high annual gross margin for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high annual gross profit margin is 92.80%
What is Y-mAbs Therapeutics annual gross margin year-on-year change?
Over the past year, YMAB annual gross profit margin has changed by -1.87% (-2.12%)
What is Y-mAbs Therapeutics quarterly gross profit margin?
The current quarterly gross margin of YMAB is 87.82%
What is the all time high quarterly gross margin for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high quarterly gross profit margin is 98.27%
What is Y-mAbs Therapeutics quarterly gross margin year-on-year change?
Over the past year, YMAB quarterly gross profit margin has changed by -3.45% (-3.78%)